PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2006
PHARMANIAGA BERHAD |
Quarterly report for the financial period ended | 31/12/2006 |
Quarter | 4 |
Financial Year End | 31/12/2006 |
The figures | have been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2006 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2006 | 31/12/2005 | 31/12/2006 | 31/12/2005 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 266,941 | 244,209 | 1,057,868 | 936,431 |
2 | Profit/(loss) before tax | -657 | 657 | 27,195 | 42,072 |
3 | Profit/(loss) for the period | -3,312 | 1,181 | 14,084 | 29,134 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | -3,680 | 1,012 | 12,481 | 26,902 |
5 | Basic earnings/(loss) per share (sen) | -3.44 | 0.95 | 11.67 | 25.98 |
6 | Proposed/Declared dividend per share (sen) | 0.00 | 0.00 | 11.50 | 14.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent (RM) | 2.9600 | 2.9400 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Remarks : |
For the current financial year ended 31 December 2006, the Board of Directors recommends a final tax exempt dividend of 15% (2005: 11.5% tax exempt dividend) on ordinary shares in issue (2005: 106,958,888) for shareholders' approval at the forthcoming Annual General Meeting. The date of the Annual General Meeting and the book closure for the final dividend payment will be announced in due course. |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 26 Feb 2007 |
Category | Financial Results |
Reference No | PB-070213-52768 |